Article
5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case.
Journal of clinical pathology - 1 May 2005
Steiner M, Seule M, Steiner B, Bauer I, Freund M, Köhne C H, Schuff-Werner P
Abstract excerpt
Combination cancer chemotherapy induced toxicity can be associated with combined pharmacogenetic syndromes. Dihydropyrimidine dehydrogenase (DPD) is the principal enzyme involved in the catabolic detoxification of 5-fluorouracil (5FU). A heterozygous G > A transition at the 5' splicing donor consensus sequence in intron 14 leading to exon 14 skipping (IVS14+1 G > A, DPYD*2A) with partial loss of enzyme activity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
